ERBB2 and non-small cell lung carcinoma: HER2 amplification, defined as a HER2/CEP17 ratio ≥2, was present in 10–20% of cases by fluorescence in situ hybridization (FISH), but only occurs in 2–4% of NSCLC cases by NGS14,15,.17